Acquired
Novo Nordisk (Ozempic)
Ben Gilbert
The last thing I want to say on the current state of GLP-1s is that not adherence is a bigger issue with these drugs than many other drugs that have come before it. There's some research that points out that as many as 68% of people roll off it after a year.
0
💬
0
Comments
Log in to comment.
There are no comments yet.